Latest news
Possible Signal As Lyell Immunopharma Insiders Sell US$527k In Stock - simplywall.stsimplywall.st · Sat, 08 Aug 2026 13:28:42 GMTLyell Immunopharma: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:39:37 GMTLyell Immunopharma reports Q2 2026 net loss $44.8M, cash $228.0M; clinical milestones advance - TradingViewTradingView · Thu, 06 Aug 2026 20:35:29 GMTLyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026 - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:05:00 GMTLYELL IMMUNOPHARMA, INC. : STIFEL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $36 - BitgetBitget · Thu, 06 Aug 2026 17:16:33 GMTThis Lyell Immunopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - BenzingaBenzinga · Thu, 06 Aug 2026 14:12:18 GMTLyell Immunopharma (NASDAQ:LYEL) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeatMarketBeat · Thu, 06 Aug 2026 13:40:43 GMTStifel initiates Lyell Immunopharma stock with buy rating on CAR T therapy - Investing.comInvesting.com · Wed, 05 Aug 2026 21:33:52 GMT